Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1997 Sep;56(9):507–509. doi: 10.1136/ard.56.9.507

Prevention of glucocorticoid induced osteoporosis

J BIJLSMA 1
PMCID: PMC1752437  PMID: 9370871

Full Text

The Full Text of this article is available as a PDF (59.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adachi J., Cranney A., Goldsmith C. H., Bensen W. G., Bianchi F., Cividino A., Craig G. L., Kaminska E., Sebaldt R. J., Papaioannou A. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss. J Rheumatol. 1994 Oct;21(10):1922–1926. [PubMed] [Google Scholar]
  2. Adinoff A. D., Hollister J. R. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med. 1983 Aug 4;309(5):265–268. doi: 10.1056/NEJM198308043090502. [DOI] [PubMed] [Google Scholar]
  3. Bijlsma J. W., Raymakers J. A., Mosch C., Hoekstra A., Derksen R. H., Baart de la Faille H., Duursma S. A. Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia. Clin Exp Rheumatol. 1988 Apr-Jun;6(2):113–119. [PubMed] [Google Scholar]
  4. Buckley L. M., Leib E. S., Cartularo K. S., Vacek P. M., Cooper S. M. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1996 Dec 15;125(12):961–968. doi: 10.7326/0003-4819-125-12-199612150-00004. [DOI] [PubMed] [Google Scholar]
  5. Cooper C., Coupland C., Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis. 1995 Jan;54(1):49–52. doi: 10.1136/ard.54.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dykman T. R., Gluck O. S., Murphy W. A., Hahn T. J., Hahn B. H. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum. 1985 Apr;28(4):361–368. doi: 10.1002/art.1780280402. [DOI] [PubMed] [Google Scholar]
  7. Eastell R. Management of corticosteroid-induced osteoporosis. UK Consensus Group Meeting on Osteoporosis. J Intern Med. 1995 May;237(5):439–447. doi: 10.1111/j.1365-2796.1995.tb00868.x. [DOI] [PubMed] [Google Scholar]
  8. Gough A. K., Lilley J., Eyre S., Holder R. L., Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet. 1994 Jul 2;344(8914):23–27. doi: 10.1016/s0140-6736(94)91049-9. [DOI] [PubMed] [Google Scholar]
  9. Hall G. M., Daniels M., Doyle D. V., Spector T. D. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids. Arthritis Rheum. 1994 Oct;37(10):1499–1505. doi: 10.1002/art.1780371014. [DOI] [PubMed] [Google Scholar]
  10. Lems W. F., Jahangier Z. N., Raymakers J. A., Jacobs J. W., Bijlsma J. W. Methods to score vertebral deformities in patients with rheumatoid arthritis. Br J Rheumatol. 1997 Feb;36(2):220–224. doi: 10.1093/rheumatology/36.2.220. [DOI] [PubMed] [Google Scholar]
  11. LoCascio V., Bonucci E., Imbimbo B., Ballanti P., Adami S., Milani S., Tartarotti D., DellaRocca C. Bone loss in response to long-term glucocorticoid therapy. Bone Miner. 1990 Jan;8(1):39–51. doi: 10.1016/0169-6009(91)90139-q. [DOI] [PubMed] [Google Scholar]
  12. Lukert B. P., Johnson B. E., Robinson R. G. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res. 1992 Sep;7(9):1063–1069. doi: 10.1002/jbmr.5650070909. [DOI] [PubMed] [Google Scholar]
  13. Lukert B. P., Raisz L. G. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med. 1990 Mar 1;112(5):352–364. doi: 10.7326/0003-4819-112-5-352. [DOI] [PubMed] [Google Scholar]
  14. Miller P. D., Bonnick S. L., Rosen C. J., Altman R. D., Avioli L. V., Dequeker J., Felsenberg D., Genant H. K., Gennari C., Harper K. D. Clinical utility of bone mass measurements in adults: consensus of an international panel. The Society for Clinical Densitometry. Semin Arthritis Rheum. 1996 Jun;25(6):361–372. doi: 10.1016/s0049-0172(96)80001-1. [DOI] [PubMed] [Google Scholar]
  15. Mulder H., Struys A. Intermittent cyclical etidronate in the prevention of corticosteroid-induced bone loss. Br J Rheumatol. 1994 Apr;33(4):348–350. doi: 10.1093/rheumatology/33.4.348. [DOI] [PubMed] [Google Scholar]
  16. Patel S. Current and potential future drug treatments for osteoporosis. Ann Rheum Dis. 1996 Oct;55(10):700–714. doi: 10.1136/ard.55.10.700. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Peat I. D., Healy S., Reid D. M., Ralston S. H. Steroid induced osteoporosis: an opportunity for prevention? Ann Rheum Dis. 1995 Jan;54(1):66–68. doi: 10.1136/ard.54.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Reid I. R., King A. R., Alexander C. J., Ibbertson H. K. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet. 1988 Jan 23;1(8578):143–146. doi: 10.1016/s0140-6736(88)92721-3. [DOI] [PubMed] [Google Scholar]
  19. Walsh L. J., Wong C. A., Pringle M., Tattersfield A. E. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ. 1996 Aug 10;313(7053):344–346. doi: 10.1136/bmj.313.7053.344. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES